MA26064A1 - Derives 1,4 de piperazine substitues utilises comme bloqueurs a1-adrenocepteur uro-selectifs. - Google Patents

Derives 1,4 de piperazine substitues utilises comme bloqueurs a1-adrenocepteur uro-selectifs.

Info

Publication number
MA26064A1
MA26064A1 MA27188A MA27188A MA26064A1 MA 26064 A1 MA26064 A1 MA 26064A1 MA 27188 A MA27188 A MA 27188A MA 27188 A MA27188 A MA 27188A MA 26064 A1 MA26064 A1 MA 26064A1
Authority
MA
Morocco
Prior art keywords
uro
selective
derivatives used
substituted piperazine
adrenoceptor blockers
Prior art date
Application number
MA27188A
Other languages
English (en)
Inventor
Anand Nitya
Jain Sanjay
Sinha Neelima
Chung Anita
Bahadur Gupta Jang
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Publication of MA26064A1 publication Critical patent/MA26064A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
MA27188A 2000-11-30 2003-05-30 Derives 1,4 de piperazine substitues utilises comme bloqueurs a1-adrenocepteur uro-selectifs. MA26064A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1097DE2000 2000-11-30

Publications (1)

Publication Number Publication Date
MA26064A1 true MA26064A1 (fr) 2004-04-01

Family

ID=11097130

Family Applications (1)

Application Number Title Priority Date Filing Date
MA27188A MA26064A1 (fr) 2000-11-30 2003-05-30 Derives 1,4 de piperazine substitues utilises comme bloqueurs a1-adrenocepteur uro-selectifs.

Country Status (25)

Country Link
US (1) US6914064B2 (fr)
EP (1) EP1339682A1 (fr)
JP (1) JP2004514711A (fr)
KR (1) KR20030068164A (fr)
CN (1) CN1230423C (fr)
AP (1) AP2003002810A0 (fr)
AR (1) AR035930A1 (fr)
AU (2) AU2231502A (fr)
BG (1) BG107943A (fr)
BR (1) BR0115865A (fr)
CA (1) CA2430343A1 (fr)
CZ (1) CZ20031698A3 (fr)
DO (1) DOP2001000296A (fr)
EA (1) EA006941B1 (fr)
EE (1) EE200300250A (fr)
HU (1) HUP0400545A3 (fr)
MA (1) MA26064A1 (fr)
MX (1) MXPA03004850A (fr)
NZ (1) NZ526226A (fr)
OA (1) OA12537A (fr)
PA (1) PA8534001A1 (fr)
PL (1) PL362210A1 (fr)
SK (1) SK8052003A3 (fr)
WO (1) WO2002044151A1 (fr)
ZA (1) ZA200304242B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050228180A1 (en) * 2002-04-08 2005-10-13 Mohammad Salman Alpha, omega-dicarboximide derivatives as useful uro-selective a1a adrenoceptor blockers
WO2005037281A1 (fr) * 2003-10-15 2005-04-28 Ranbaxy Laboratories Limited Derives de 1-alkylpiperazinyl-pyrrolidin-2,5-dione utiles comme antagonistes du recepteur adrenergique
WO2005092341A1 (fr) * 2004-03-22 2005-10-06 Ranbaxy Laboratories Limited Therapie combinee destinee a reduire les symptomes des voies urinaires
WO2005113498A1 (fr) * 2004-05-19 2005-12-01 Ranbaxy Laboratories Limited Antagonistes du recepteur adrenergique
US20090312344A1 (en) * 2004-05-31 2009-12-17 Mohammad Salman Arylpiperazine derivatives as adrenergic receptor antagonists
WO2006018815A1 (fr) * 2004-08-16 2006-02-23 Ranbaxy Laboratories Limited Derives de piperazine utilises comme antagonistes de recepteurs adrenergiques
WO2006051374A2 (fr) * 2004-11-11 2006-05-18 Ranbaxy Laboratories Limited Antagonistes des recepteurs adrenergiques
WO2006051399A1 (fr) * 2004-11-11 2006-05-18 Ranbaxy Laboratories Limited Derives de piperazine utiles en tant qu'antagonistes des recepteurs adrenergiques
WO2006092710A1 (fr) * 2005-03-02 2006-09-08 Ranbaxy Laboratories Limited Metabolites de la 2-{3-[4-(2-isopropoxyphenyl)piperazin-1-yl]-propyl}-3a,4,7,7a-tetrahydro-1h-isoindole-1,3-(2h)-dione
WO2006117760A1 (fr) * 2005-05-03 2006-11-09 Ranbaxy Laboratories Limited Antagonistes de recepteurs adrenergiques
WO2007029156A2 (fr) * 2005-09-05 2007-03-15 Ranbaxy Laboratories Limited Derives d'isoindoledione comme antagonistes de recepteurs adrenergiques
WO2007039809A1 (fr) * 2005-10-05 2007-04-12 Ranbaxy Laboratories Limited Métabolites de 2- {3-[4-(5-fluoro-2-isopropoxy-phényl)-pipérazin-1-yl]-propyl} -5,6-dihydroxy-hexahydro-isoindol-1,3-dione
US9227944B2 (en) 2008-10-10 2016-01-05 Institute Of Pharmacology And Toxicology Academy Of Military Science P.L.A. China Dopamine D3 receptor ligands and preparation and medical uses of the same
EP2354136B1 (fr) 2008-10-10 2016-02-24 Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China Nouveaux ligands de récepteurs d3 de la dopamine, leurs procédés de préparation et leurs applications
CA3042927C (fr) 2009-05-05 2022-05-17 Arbutus Biopharma Corporation Compositions de lipides servant a distribuer des agents therapeutiques

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57197265A (en) * 1981-05-29 1982-12-03 Eisai Co Ltd Carboxylic acid imide derivative, its preparation and medicament containing the same
JPS5936661A (ja) * 1982-08-26 1984-02-28 Eisai Co Ltd カルボン酸イミド誘導体およびその製造方法ならびにそれを含有する医薬
JPS5976059A (ja) * 1982-10-21 1984-04-28 Sumitomo Chem Co Ltd 環状イミド誘導体及びその酸付加塩
JPS5995267A (ja) * 1982-11-25 1984-06-01 Eisai Co Ltd カルボン酸イミド誘導体およびその製造方法
US4524206A (en) * 1983-09-12 1985-06-18 Mead Johnson & Company 1-Heteroaryl-4-(2,5-pyrrolidinedion-1-yl)alkyl)piperazine derivatives
AT387773B (de) * 1983-09-12 1989-03-10 Bristol Myers Co Verfahren zur herstellung von 1-heteroaryl-4-((2,5-pyrrolidindion-1-yl)aklyl) iperazin-derivaten
JPS60204784A (ja) 1984-03-29 1985-10-16 Eisai Co Ltd カルボン酸イミド誘導体
JP2918899B2 (ja) 1989-03-09 1999-07-12 住友製薬株式会社 環状イミド誘導体の製造方法
US5688795A (en) * 1994-11-08 1997-11-18 Syntex (U.S.A.) Inc. 3-(4-phenylpiperazin-1-yl)propyl-amino, thio and oxy!-pyridine, pyrimidine and benzene derivatives as α1 -adrenoceptor antagonists
ATE201016T1 (de) * 1995-06-09 2001-05-15 Hoffmann La Roche Pyrimidindion-, pyrimidintrion-, triazindion- derivate als alpha-1-adrenergische rezeptorantagonisten
WO1998037893A1 (fr) 1997-02-26 1998-09-03 Sumitomo Pharmaceuticals Co., Ltd. Antagoniste du recepteur dopaminergique d4
DK0984777T3 (da) * 1997-05-12 2003-12-08 Ortho Mcneil Pharm Inc Arylsubstituerede piperaziner, der er anvendelige ved behandlingen af godartet prostatisk hyperplasi
US6083950A (en) * 1997-11-13 2000-07-04 Ranbaxy Laboratories Limited 1-(4-arylpiperazin-1-yl)-ω-[n-(α,ω-dicarboximido)]-alka nes useful as uro-selective α1-adrenoceptor blockers

Also Published As

Publication number Publication date
AU2002222315B2 (en) 2007-06-21
EE200300250A (et) 2003-10-15
CA2430343A1 (fr) 2002-06-06
CZ20031698A3 (cs) 2003-11-12
CN1486300A (zh) 2004-03-31
WO2002044151A1 (fr) 2002-06-06
EA200300620A1 (ru) 2003-12-25
BR0115865A (pt) 2003-12-23
HUP0400545A2 (hu) 2004-07-28
AR035930A1 (es) 2004-07-28
AP2003002810A0 (en) 2003-06-30
AU2231502A (en) 2002-06-11
US6914064B2 (en) 2005-07-05
EP1339682A1 (fr) 2003-09-03
BG107943A (bg) 2004-08-31
EA006941B1 (ru) 2006-06-30
CN1230423C (zh) 2005-12-07
PL362210A1 (en) 2004-10-18
DOP2001000296A (es) 2003-03-15
PA8534001A1 (es) 2002-12-11
KR20030068164A (ko) 2003-08-19
SK8052003A3 (en) 2003-12-02
JP2004514711A (ja) 2004-05-20
US20020156085A1 (en) 2002-10-24
ZA200304242B (en) 2004-03-02
NZ526226A (en) 2004-05-28
MXPA03004850A (es) 2004-01-26
OA12537A (en) 2006-06-05
HUP0400545A3 (en) 2007-05-02

Similar Documents

Publication Publication Date Title
MA26601A1 (fr) Derives 2-(purin-9yl)-tetrahydrofurant-3,4-diol .
MA26887A1 (fr) Derives de piperazine nouveaux.
DK1114031T3 (da) 4-carboxyamino-2-substituerede 1,2,3,4.tetrahydroquinoliner som CETP-inhibitorer
DE60214428D1 (de) 1, 4-dihydro-1, 4-diphenylpyridin-derivate
DE69933287D1 (de) 12,13-modifizierte epothilon-derivate
DK1114032T3 (da) 4-aminosubstituerede-2-substituerede-1,2,3,4-tetrahydroquinoliner som CETB-inhibitorer
ATE240327T1 (de) 1,2-annelierte chinolinderivate
NO20043022L (no) 5,6-diaryl-pyrazin-2-amid-derivater som CB1-antagonister
DE60019577D1 (de) 4, 5, 6, 7-tetrahydroindazolderivate als antitumormittel
DZ3327A1 (fr) Derives de benzimidazole nouveaux utiles comme agents antiproliferatifs.
DE59911323D1 (de) Niedrigkonzentrierte, hochviskose wässrige Weichspülmittel
MA26064A1 (fr) Derives 1,4 de piperazine substitues utilises comme bloqueurs a1-adrenocepteur uro-selectifs.
MA26846A1 (fr) Derives de 2,4-diaminopyrimidine utiles comme agents immunosuppresseurs.
BR0013417B1 (pt) composiÇço aquosa.
DE50107988D1 (de) Substituierte 1,2,3,4-tetrahydrochinolin-2-carbonsäurederivate
EE200000447A (et) 1,3,4-oksadiasolooni derivaadid
ATE317396T1 (de) 14,15-beta-methylen substituierte androgene
NO20024502L (no) 4-okso-1,4-dihydro-3-cinnolinkarboksamider som antivirale midler
NO20015397D0 (no) 1,5-Benzodiazepin-derivater
IS7131A (is) Nýjar 2,4-díamínóþíasól afleiður
ATE470655T1 (de) Substituierte 1,5-diaminopentan-3-ol-verbindungen
ITTV980121A0 (it) Tavolo pensile.
DK1274687T3 (da) 1,2,3,4-tetrahydroisoquinolinderivater
IS7299A (is) 3,4-díhýdró-1H-ísókínólóín-2-ýl-afleiður
ITMI20010486A1 (it) Macchina i.s.